PLEKHD1: A Potential Drug Target for T-Cell Development and Function

Target Name: PLEKHD1

NCBI ID: G400224

PLEKHD1

Other Name(s): UPF0639 | Pleckstrin homology and coiled-coil domain containing D1 | PH domain-containing family D member 1 | pleckstrin homology domain containing, family D (with coiled-coil domains) member 1 | pleckstrin homology and coiled-coil domain containing D1 | UPF0639 protein | Pleckstrin homology domain containing, family D (with M protein repeats) member 1 | PLHD1_HUMAN | pleckstrin homology domain containing, family D (with M protein repeats) member 1 | Pleckstrin homology domain-containing family D member 1

PLEKHD1: A Potential Drug Target for T-Cell Development and Function

PLEKHD1 (UPF0639) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the T-cell antigen receptor (TAR) family and is involved in the regulation of T- cell development and function. PLEKHD1 has been identified as a potential drug target in the field of immunology due to its involvement in the immune response and its potential to modulate the activity of T-cells.

The T-cell antigen receptor (TAR) family is a group of transmembrane proteins that are involved in the regulation of T-cell development and function. These proteins are characterized by the presence of a transmembrane domain and a variable extracellular domain. PLEKHD1 is a member of this family and is expressed in various tissues throughout the body, including the brain, heart, and kidneys.

PLEKHD1 is involved in the regulation of T-cell development and function by regulating the activity of the T-cell receptor (TCR), which is a protein that is responsible for recognizing antigens in the environment. The TCR is composed of a伪 chain and 尾 chain, and it consists of a transmembrane domain and a variable extracellular domain. PLEKHD1 is known to modulate the activity of the TCR by interacting with the alpha chain of the TCR and influencing the tyrosination of the alpha chain.

PLEKHD1 has been shown to play a role in the regulation of T-cell receptor (TCR) function. Studies have shown that PLEKHD1 can modulate the activity of the TCR by interacting with the alpha chain of the TCR and influencing the tyrosination of the alpha chain . This interaction between PLEKHD1 and the TCR has implications for the regulation of T-cell development and function.

In addition to its role in T-cell development and function, PLEKHD1 has also been shown to play a role in the regulation of inflammation. PLEKHD1 has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as interleukin -1 (IL-1), by modulating the activity of various transcription factors, including nuclear factor kappa B (NF-kappa-B).

PLEKHD1 has also been shown to play a role in the regulation of cell survival. Studies have shown that PLEKHD1 can modulate the activity of various cellular signaling pathways, including the T-cell signaling pathway, which is involved in the regulation of cell survival. This Modulation of cellular signaling pathways by PLEKHD1 has implications for the regulation of cancer cell survival.

In conclusion, PLEKHD1 is a protein that is involved in the regulation of T-cell development and function by modulating the activity of the TCR. PLEKHD1 has also been shown to play a role in the regulation of inflammation and cell survival. Based on these findings , PLEKHD1 is a potential drug target in the field of immunology. Further research is needed to fully understand the role of PLEKHD1 in the regulation of T-cell development and function, as well as its potential as a drug target.

Protein Name: Pleckstrin Homology And Coiled-coil Domain Containing D1

The "PLEKHD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLEKHD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets